fullPIERS Model in the Prediction of Adverse Maternal Outcomes in Preeclampsia
NCT07316140 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2026-01-05
Summary
Apredictive formula, fullPIERS (Pre-eclampsia Integrated Estimate of Risk Score), can be used to estimate the risk of suffering an adverse outcome using information obtained within 48 hours of admission with pre-eclampsia. The following information is used, serum creatinine, gestational age, platelet count,
Conditions
- Preeclampsia
- Fullpairs
Sponsors & Collaborators
-
Sohag University
lead OTHER
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-01-01
- Primary Completion
- 2026-01-01
- Completion
- 2026-09-01
Countries
- Egypt
Study Locations
More Related Trials
-
Predicting Late-onset Preeclampsia at 10-14 Weeks of Pregnancy
NCT04075708 ·Status: COMPLETED
-
Kidney Injury Biomarkers in Preeclampsia
NCT03217916 ·Status: UNKNOWN
-
New Magnesium Sulphate Protocol for Pre-eclampsia
NCT01846156 ·Status: COMPLETED ·Phase: PHASE3
-
Placental Protein 13 Serum Endoglin and Uterine Doppler Indeces as Predictors of Pre-eclampsia
NCT02350036 ·Status: COMPLETED
-
Evaluation of Neutrophil/Lymphocyte Ratio ,Platelet/Lymphocyte Ratio and CRP as Markers of Severity of Pre-eclampsia
NCT03630276 ·Status: UNKNOWN ·Phase: NA
-
Pulmonary Artery Doppler in Preeclamptic Mothers
NCT06755073 ·Status: COMPLETED
-
Biomarkers and Preeclampsia Outcomes
NCT03801447 ·Status: COMPLETED
-
PIERS and BIS, sFIT:PIGF, Adrenomedullin
NCT02578810 ·Status: RECRUITING
-
Precision Medicine for Prediction & Prevention of Early Pre-eclampsia
NCT04412681 ·Status: UNKNOWN ·Phase: NA
-
sFlt-1/PlGF Ratio: Impact on the Management of Patients With Suspected Pre-eclampsia
NCT05228002 ·Status: COMPLETED ·Phase: NA
-
Maternal and Neonatal Outcome in Severe Preeclampsia
NCT04126122 ·Status: UNKNOWN
-
Preeclampsia Risk Assessment: Evaluation of Cut-offs to Improve Stratification
NCT03815110 ·Status: COMPLETED
-
Prediction of Early Pre-eclampsia From Maternal Factors, Biophysical and Biochemical Markers at First Trimester
NCT02990767 ·Status: UNKNOWN
-
Vascular Endothelial Factor Gene Polymorphism in Preeclampsia
NCT03500588 ·Status: COMPLETED
-
CA-125 and Severity of Pre-Eclampsia
NCT02704676 ·Status: UNKNOWN
-
Comparison Between Uterine Artery Doppler and Placental Vascular Indices in Prediction of Preeclampsia
NCT03838887 ·Status: UNKNOWN
-
Early Placental Insufficiency Screening
NCT01348711 ·Status: TERMINATED
-
Risk Analysis of Intensive Care Mangement on Maternal and Fetal Outcome of Severe Preeclampsia and Eclampsia
NCT03412552 ·Status: COMPLETED
-
Promising Bimarker Prediction of Outcome of HELLP Syndrome.
NCT03246542 ·Status: COMPLETED
-
Preeclampsia Ratio (sFlt-1/PlGF)
NCT03289611 ·Status: COMPLETED ·Phase: NA
-
Prediction of Preeclampsia by Comprehensive Markers.
NCT03665623 ·Status: COMPLETED
-
Role of Vaspin in Pathophysiology of Pre-eclampsia
NCT06437535 ·Status: NOT_YET_RECRUITING
-
Serum Androgen Levels as a Marker for the Severity of Preeclampsia
NCT03744988 ·Status: UNKNOWN
-
Risk Prediction Models for Adverse Maternal and Neonatal Outcomes in Preeclampsia
NCT04058405 ·Status: COMPLETED
-
Factors Predicting Transformation of Non Severe Pre-eclampsia Into Pre-eclampsia With Severe Features
NCT05152550 ·Status: UNKNOWN